LAMEA Sepsis Diagnostics Market Size, Share & Industry Trends Analysis Report By Method, By Test Type, By Pathogen, By Product, By End-User, By Technology, By Country and Growth Forecast, 2022 - 2028

The Latin America, Middle East and Africa Sepsis Diagnostics Market would witness market growth of 14.0% CAGR during the forecast period (2022-2028).

Children account for a significant proportion of the total instances of sepsis diagnosed each year, leading to a considerable number of deaths annually, the majority of which might be avoided with early identification and adequate clinical therapy. Diarrheal illnesses or respiratory illnesses are frequently the cause of these deaths. Obstetric infections, such as infections after an abortion or infections after a caesarean section, are the third leading cause of maternal death.

Biosensors that monitor biological or chemical interactions are frequently used to diagnose sepsis. Biosensors are devices that produce a signal proportional to analyses concentrations in biological samples. Biosensors are made up of a variety of components, including analyses, bio receptors, signal transducers, and display panels. Biosensors can identify low signals in a range of biological fluids using a minimal number of samples. Nanotechnology-based biosensors offer a revolutionary diagnostic technique that improves biomarker sensitivity and processing speed without requiring professional abilities. Biomarkers are frequently used in sepsis management for diagnostic, monitoring, prognostic, surrogate, and stratification purposes. PCT, CRP, and Interleukin-6 are three biomarkers that have proven useful in the clinical diagnosis of sepsis.

There is a significant prevalence of sepsis in Africa. According to the African Sepsis Alliance, in Africa, at least 2 million people die from sepsis each year. In addition, these figures, however, are likely to be grossly underestimated, because sepsis is rarely identified, recognized, or recorded as a cause of death in Africa. Sepsis is the third leading cause of maternal death, contributing to 11% of all maternal fatalities. Africa is predicted to have a greater incidence of maternal deaths due to sepsis, which accounts for two-thirds of infant deaths. Moreover, sepsis is a major public health issue that affects people in this region.

In well-resourced healthcare systems, there is substantial research into techniques to improve survival. Furthermore, since its beginning, the Enduring Sepsis Campaign has succeeded in elevating the profile of sepsis by raising awareness and offering evidence-based recommendations for optimal management, education, and performance improvement.

The Brazil market dominated the LAMEA Sepsis Diagnostics Market by Country in 2021, and would continue to be a dominant market till 2018; thereby, achieving a market value of $20.7 million by 2028. The Argentina market is anticipated to grow at a CAGR of 14.6% during (2022 - 2028). Additionally, The UAE market would experience a CAGR of 13.7% during (2022 - 2028).

Based on Method, the market is segmented into Conventional and Automated. Based on Test Type, the market is segmented into Laboratory Tests and Point-of-Care Tests. Based on Pathogen, the market is segmented into Bacterial Sepsis, Fungal Sepsis, Viral Sepsis, and Others. Based on Product, the market is segmented into Blood Culture Media, Assays & Reagents, Instruments, and Software. Based on End-User, the market is segmented into Hospitals & specialty clinics, Pathology & Reference Laboratories, and Research Laboratories & Academic Institutes. Based on Technology, the market is segmented into Blood Culture, Immunoassays, Molecular Diagnostics, Flow Cytometry, Microfluidics, and Biomarkers. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BioMérieux S.A., F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Abbott Laboratories, Thermo Fisher Scientific, Inc., DiaSorin S.p.A., Bruker Corporation, Siemens Healthineers AG, Danaher Corporation, and Quidel Corporation.

Free Valuable Insights: The Global Sepsis Diagnostics MarketMarket is Predict to reach $879.5 Million by 2028, at a CAGR of 8.3%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BioMérieux S.A., F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Abbott Laboratories, Thermo Fisher Scientific, Inc., DiaSorin S.p.A., Bruker Corporation, Siemens Healthineers AG, Danaher Corporation, and Quidel Corporation.

Scope of the Study

Market Segments Covered in the Report:

By Method

• Conventional
• Automated

By Test Type

• Laboratory Tests
• Point-of-Care Tests

By Pathogen

• Bacterial Sepsis
• Fungal Sepsis
• Viral Sepsis
• Others

By Product

• Blood Culture Media
• Assays & Reagents
• Instruments
• Software

By End-User

• Hospitals & specialty clinics
• Pathology & Reference Laboratories
• Research Laboratories & Academic Institutes

By Technology

• Blood Culture
• Immunoassays
• Molecular Diagnostics
• Flow Cytometry
• Microfluidics
• Biomarkers

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• BioMérieux S.A.
• F. Hoffmann-La Roche Ltd.
• Becton, Dickinson and Company
• Abbott Laboratories
• Thermo Fisher Scientific, Inc.
• DiaSorin S.p.A.
• Bruker Corporation
• Siemens Healthineers AG
• Danaher Corporation
• Quidel Corporation

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Sepsis Diagnostics Market, by Method
1.4.2 LAMEA Sepsis Diagnostics Market, by Test Type
1.4.3 LAMEA Sepsis Diagnostics Market, by Pathogen
1.4.4 LAMEA Sepsis Diagnostics Market, by Product
1.4.5 LAMEA Sepsis Diagnostics Market, by End-User
1.4.6 LAMEA Sepsis Diagnostics Market, by Technology
1.4.7 LAMEA Sepsis Diagnostics Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2018, Jul – 2021, Dec) Leading Players

Chapter 4. LAMEA Sepsis Diagnostics Market by Method
4.1 LAMEA Conventional Market by Country
4.2 LAMEA Automated Market by Country

Chapter 5. LAMEA Sepsis Diagnostics Market by Test Type
5.1 LAMEA Laboratory Tests Market by Country
5.2 LAMEA Point-of-Care Tests Market by Country

Chapter 6. LAMEA Sepsis Diagnostics Market by Pathogen
6.1 LAMEA Bacterial Sepsis Market by Country
6.2 LAMEA Fungal Sepsis Market by Country
6.3 LAMEA Viral Sepsis Market by Country
6.4 LAMEA Others Market by Country

Chapter 7. LAMEA Sepsis Diagnostics Market by Product
7.1 LAMEA Blood Culture Media Market by Country
7.2 LAMEA Assays & Reagents Market by Country
7.3 LAMEA Instruments Market by Country
7.4 LAMEA Software Market by Country

Chapter 8. LAMEA Sepsis Diagnostics Market by End-User
8.1 LAMEA Hospitals & specialty clinics Market by Country
8.2 LAMEA Pathology & Reference Laboratories Market by Country
8.3 LAMEA Research Laboratories & Academic Institutes Market by Country

Chapter 9. LAMEA Sepsis Diagnostics Market by Technology
9.1 LAMEA Blood Culture Market by Country
9.2 LAMEA Immunoassays Market by Country
9.3 LAMEA Molecular Diagnostics Market by Country
9.4 LAMEA Flow Cytometry Market by Country
9.5 LAMEA Microfluidics Market by Country
9.6 LAMEA Biomarkers Market by Country

Chapter 10. LAMEA Sepsis Diagnostics Market by Country
10.1 Brazil Sepsis Diagnostics Market
10.1.1 Brazil Sepsis Diagnostics Market by Method
10.1.2 Brazil Sepsis Diagnostics Market by Test Type
10.1.3 Brazil Sepsis Diagnostics Market by Pathogen
10.1.4 Brazil Sepsis Diagnostics Market by Product
10.1.5 Brazil Sepsis Diagnostics Market by End-User
10.1.6 Brazil Sepsis Diagnostics Market by Technology
10.2 Argentina Sepsis Diagnostics Market
10.2.1 Argentina Sepsis Diagnostics Market by Method
10.2.2 Argentina Sepsis Diagnostics Market by Test Type
10.2.3 Argentina Sepsis Diagnostics Market by Pathogen
10.2.4 Argentina Sepsis Diagnostics Market by Product
10.2.5 Argentina Sepsis Diagnostics Market by End-User
10.2.6 Argentina Sepsis Diagnostics Market by Technology
10.3 UAE Sepsis Diagnostics Market
10.3.1 UAE Sepsis Diagnostics Market by Method
10.3.2 UAE Sepsis Diagnostics Market by Test Type
10.3.3 UAE Sepsis Diagnostics Market by Pathogen
10.3.4 UAE Sepsis Diagnostics Market by Product
10.3.5 UAE Sepsis Diagnostics Market by End-User
10.3.6 UAE Sepsis Diagnostics Market by Technology
10.4 Saudi Arabia Sepsis Diagnostics Market
10.4.1 Saudi Arabia Sepsis Diagnostics Market by Method
10.4.2 Saudi Arabia Sepsis Diagnostics Market by Test Type
10.4.3 Saudi Arabia Sepsis Diagnostics Market by Pathogen
10.4.4 Saudi Arabia Sepsis Diagnostics Market by Product
10.4.5 Saudi Arabia Sepsis Diagnostics Market by End-User
10.4.6 Saudi Arabia Sepsis Diagnostics Market by Technology
10.5 South Africa Sepsis Diagnostics Market
10.5.1 South Africa Sepsis Diagnostics Market by Method
10.5.2 South Africa Sepsis Diagnostics Market by Test Type
10.5.3 South Africa Sepsis Diagnostics Market by Pathogen
10.5.4 South Africa Sepsis Diagnostics Market by Product
10.5.5 South Africa Sepsis Diagnostics Market by End-User
10.5.6 South Africa Sepsis Diagnostics Market by Technology
10.6 Nigeria Sepsis Diagnostics Market
10.6.1 Nigeria Sepsis Diagnostics Market by Method
10.6.2 Nigeria Sepsis Diagnostics Market by Test Type
10.6.3 Nigeria Sepsis Diagnostics Market by Pathogen
10.6.4 Nigeria Sepsis Diagnostics Market by Product
10.6.5 Nigeria Sepsis Diagnostics Market by End-User
10.6.6 Nigeria Sepsis Diagnostics Market by Technology
10.7 Rest of LAMEA Sepsis Diagnostics Market
10.7.1 Rest of LAMEA Sepsis Diagnostics Market by Method
10.7.2 Rest of LAMEA Sepsis Diagnostics Market by Test Type
10.7.3 Rest of LAMEA Sepsis Diagnostics Market by Pathogen
10.7.4 Rest of LAMEA Sepsis Diagnostics Market by Product
10.7.5 Rest of LAMEA Sepsis Diagnostics Market by End-User
10.7.6 Rest of LAMEA Sepsis Diagnostics Market by Technology

Chapter 11. Company Profiles
11.1 BioMérieux S.A.
11.1.1 Company Overview
11.1.2 Financial Analysis
11.1.3 Segmental and Regional Analysis
11.1.4 Research & Development Expenses
11.1.5 Recent strategies and developments:
11.1.5.1 Acquisition and Mergers:
11.2 F. Hoffmann-La Roche Ltd.
11.2.1 Company Overview
11.2.2 Financial Analysis
11.2.3 Segmental and Regional Analysis
11.2.4 Research & Development Expense
11.2.5 Recent strategies and developments:
11.2.5.1 Partnerships, Collaborations, and Agreements:
11.2.5.2 Approvals and Trials:
11.3 Becton, Dickinson and Company
11.3.1 Company Overview
11.3.2 Financial Analysis
11.3.3 Segmental and Regional Analysis
11.3.4 Research & Development Expense
11.3.5 Recent strategies and developments:
11.3.5.1 Product Launches and Product Expansions:
11.4 Abbott Laboratories
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Segmental and Regional Analysis
11.4.4 Research & Development Expense
11.4.5 Recent strategies and developments:
11.4.5.1 Acquisition and Mergers:
11.5 Thermo Fisher Scientific, Inc.
11.5.1 Company Overview
11.5.2 Financial Analysis
11.5.3 Segmental and Regional Analysis
11.5.4 Research & Development Expense
11.5.5 Recent strategies and developments:
11.5.5.1 Partnerships, Collaborations, and Agreements:
11.5.5.2 Approvals and Trials:
11.5.5.3 Acquisition and Mergers:
11.5.6 SWOT Analysis
11.6 DiaSorin S.p.A. (Luminex Corporation)
11.6.1 Company Overview
11.6.2 Financial Analysis
11.6.3 Regional Analysis
11.6.4 Research & Development Expenses
11.6.5 Recent strategies and developments:
11.6.5.1 Acquisitions and Mergers:
11.7 Bruker Corporation
11.7.1 Company Overview
11.7.2 Financial Analysis
11.7.3 Segmental and Regional Analysis
11.7.4 Research & Development Expense
11.7.5 Recent strategies and developments:
11.7.5.1 Product Launches and Product Expansions:
11.7.5.2 Acquisition and Mergers:
11.8 Siemens Healthineers AG (Siemens AG)
11.8.1 Company Overview
11.8.2 Financial Analysis
11.8.3 Segmental and Regional Analysis
11.8.4 Research & Development Expenses
11.8.5 Recent strategies and developments:
11.8.5.1 Partnerships, Collaborations, and Agreements:
11.8.5.2 Acquisition and Mergers:
11.9 Danaher Corporation
11.9.1 Company Overview
11.9.2 Financial Analysis
11.9.3 Segmental and Regional Analysis
11.9.4 Research & Development Expense
11.10. Quidel Corporation
11.10.1 Company Overview
11.10.2 Financial Analysis
11.10.3 Regional Analysis
11.10.4 Research & Development Expense
11.10.5 Recent strategies and developments:
11.10.5.1 Acquisition and Mergers:

TABLE 1 LAMEA Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements – Sepsis Diagnostics Market
TABLE 4 Product Launches And Product Expansions – Sepsis Diagnostics Market
TABLE 5 Acquisition and Mergers – Sepsis Diagnostics Market
TABLE 6 Approvals and Trials – Sepsis Diagnostics Market
TABLE 7 LAMEA Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 8 LAMEA Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 9 LAMEA Conventional Market by Country, 2018 - 2021, USD Million
TABLE 10 LAMEA Conventional Market by Country, 2022 - 2028, USD Million
TABLE 11 LAMEA Automated Market by Country, 2018 - 2021, USD Million
TABLE 12 LAMEA Automated Market by Country, 2022 - 2028, USD Million
TABLE 13 LAMEA Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 14 LAMEA Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 15 LAMEA Laboratory Tests Market by Country, 2018 - 2021, USD Million
TABLE 16 LAMEA Laboratory Tests Market by Country, 2022 - 2028, USD Million
TABLE 17 LAMEA Point-of-Care Tests Market by Country, 2018 - 2021, USD Million
TABLE 18 LAMEA Point-of-Care Tests Market by Country, 2022 - 2028, USD Million
TABLE 19 LAMEA Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 20 LAMEA Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 21 LAMEA Bacterial Sepsis Market by Country, 2018 - 2021, USD Million
TABLE 22 LAMEA Bacterial Sepsis Market by Country, 2022 - 2028, USD Million
TABLE 23 LAMEA Fungal Sepsis Market by Country, 2018 - 2021, USD Million
TABLE 24 LAMEA Fungal Sepsis Market by Country, 2022 - 2028, USD Million
TABLE 25 LAMEA Viral Sepsis Market by Country, 2018 - 2021, USD Million
TABLE 26 LAMEA Viral Sepsis Market by Country, 2022 - 2028, USD Million
TABLE 27 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 28 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 29 LAMEA Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 30 LAMEA Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 31 LAMEA Blood Culture Media Market by Country, 2018 - 2021, USD Million
TABLE 32 LAMEA Blood Culture Media Market by Country, 2022 - 2028, USD Million
TABLE 33 LAMEA Assays & Reagents Market by Country, 2018 - 2021, USD Million
TABLE 34 LAMEA Assays & Reagents Market by Country, 2022 - 2028, USD Million
TABLE 35 LAMEA Instruments Market by Country, 2018 - 2021, USD Million
TABLE 36 LAMEA Instruments Market by Country, 2022 - 2028, USD Million
TABLE 37 LAMEA Software Market by Country, 2018 - 2021, USD Million
TABLE 38 LAMEA Software Market by Country, 2022 - 2028, USD Million
TABLE 39 LAMEA Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 40 LAMEA Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 41 LAMEA Hospitals & specialty clinics Market by Country, 2018 - 2021, USD Million
TABLE 42 LAMEA Hospitals & specialty clinics Market by Country, 2022 - 2028, USD Million
TABLE 43 LAMEA Pathology & Reference Laboratories Market by Country, 2018 - 2021, USD Million
TABLE 44 LAMEA Pathology & Reference Laboratories Market by Country, 2022 - 2028, USD Million
TABLE 45 LAMEA Research Laboratories & Academic Institutes Market by Country, 2018 - 2021, USD Million
TABLE 46 LAMEA Research Laboratories & Academic Institutes Market by Country, 2022 - 2028, USD Million
TABLE 47 LAMEA Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 48 LAMEA Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 49 LAMEA Blood Culture Market by Country, 2018 - 2021, USD Million
TABLE 50 LAMEA Blood Culture Market by Country, 2022 - 2028, USD Million
TABLE 51 LAMEA Immunoassays Market by Country, 2018 - 2021, USD Million
TABLE 52 LAMEA Immunoassays Market by Country, 2022 - 2028, USD Million
TABLE 53 LAMEA Molecular Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 54 LAMEA Molecular Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 55 LAMEA Flow Cytometry Market by Country, 2018 - 2021, USD Million
TABLE 56 LAMEA Flow Cytometry Market by Country, 2022 - 2028, USD Million
TABLE 57 LAMEA Microfluidics Market by Country, 2018 - 2021, USD Million
TABLE 58 LAMEA Microfluidics Market by Country, 2022 - 2028, USD Million
TABLE 59 LAMEA Biomarkers Market by Country, 2018 - 2021, USD Million
TABLE 60 LAMEA Biomarkers Market by Country, 2022 - 2028, USD Million
TABLE 61 LAMEA Sepsis Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 62 LAMEA Sepsis Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 63 Brazil Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 64 Brazil Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 65 Brazil Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 66 Brazil Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 67 Brazil Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 68 Brazil Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 69 Brazil Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 70 Brazil Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 71 Brazil Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 72 Brazil Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 73 Brazil Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 74 Brazil Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 75 Brazil Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 76 Brazil Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 77 Argentina Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 78 Argentina Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 79 Argentina Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 80 Argentina Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 81 Argentina Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 82 Argentina Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 83 Argentina Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 84 Argentina Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 85 Argentina Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 86 Argentina Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 87 Argentina Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 88 Argentina Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 89 Argentina Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 90 Argentina Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 91 UAE Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 92 UAE Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 93 UAE Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 94 UAE Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 95 UAE Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 96 UAE Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 97 UAE Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 98 UAE Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 99 UAE Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 100 UAE Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 101 UAE Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 102 UAE Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 103 UAE Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 104 UAE Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 105 Saudi Arabia Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 106 Saudi Arabia Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 107 Saudi Arabia Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 108 Saudi Arabia Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 109 Saudi Arabia Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 110 Saudi Arabia Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 111 Saudi Arabia Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 112 Saudi Arabia Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 113 Saudi Arabia Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 114 Saudi Arabia Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 115 Saudi Arabia Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 116 Saudi Arabia Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 117 Saudi Arabia Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 118 Saudi Arabia Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 119 South Africa Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 120 South Africa Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 121 South Africa Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 122 South Africa Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 123 South Africa Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 124 South Africa Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 125 South Africa Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 126 South Africa Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 127 South Africa Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 128 South Africa Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 129 South Africa Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 130 South Africa Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 131 South Africa Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 132 South Africa Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 133 Nigeria Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 134 Nigeria Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 135 Nigeria Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 136 Nigeria Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 137 Nigeria Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 138 Nigeria Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 139 Nigeria Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 140 Nigeria Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 141 Nigeria Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 142 Nigeria Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 143 Nigeria Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 144 Nigeria Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 145 Nigeria Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 146 Nigeria Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 147 Rest of LAMEA Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 148 Rest of LAMEA Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 149 Rest of LAMEA Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 150 Rest of LAMEA Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 151 Rest of LAMEA Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 152 Rest of LAMEA Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 153 Rest of LAMEA Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 154 Rest of LAMEA Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 155 Rest of LAMEA Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 156 Rest of LAMEA Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 157 Rest of LAMEA Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 158 Rest of LAMEA Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 159 Rest of LAMEA Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 160 Rest of LAMEA Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 161 Key information – BioMérieux S.A.
TABLE 162 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.
TABLE 163 Key information – Becton, Dickinson and Company
TABLE 164 Key Information – Abbott Laboratories
TABLE 165 Key Information – Thermo Fisher Scientific, Inc.
TABLE 166 Key Information – DiaSorin S.p.A.
TABLE 167 Key Information – Bruker Corporation
TABLE 168 Key Information – Siemens Healthineers AG
TABLE 169 Key Information – Danaher Corporation
TABLE 170 key information – Quidel Corporation

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Acquisitions and Mergers: 2018, Jul – 2021, Dec) Leading Players
FIG 5 Recent strategies and developments: Thermo Fisher Scientific, Inc.
FIG 6 Swot analysis: thermo fisher scientific, inc.
FIG 7 Recent strategies and developments: Bruker Corporation